Case Report of Non-small Cell Lung Cancer Patient with EGFR T790M Mutation Treated with Th ird Generation Inhibitor
dc.contributor.author | Doval, Dinesh Chandra | en_US |
dc.contributor.author | Tripathi, Rupal | en_US |
dc.contributor.author | Choudhury, Kumardeep Dutta | en_US |
dc.contributor.author | Sharma, Ajay | en_US |
dc.contributor.author | Batra, Ullas | en_US |
dc.contributor.author | Mehta, Anurag | en_US |
dc.contributor.author | Choudhury, PS | en_US |
dc.date.accessioned | 2020-04-10T01:55:02Z | |
dc.date.available | 2020-04-10T01:55:02Z | |
dc.date.issued | 2019-01 | |
dc.description.abstract | Lung cancer treatment based on the molecular classifi cation of the tumor has paved the way for multiple lines of targeted treatment, even though the development of resistance remains a major cause of concern. Epidermal growth factor receptor (EGFR) remains the poster boy for the use of targeted therapy, and the presence/absence of mutations in this gene has led to the development of inhibitors targeting specifi c mutations. We present the case of an advanced non-small cell lung cancer patient with EGFR T790M mutation treated with Osimertinib, a third-generation inhibitor. | en_US |
dc.identifier.affiliations | Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India | en_US |
dc.identifier.affiliations | Department of Research, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India | en_US |
dc.identifier.affiliations | Department of Laboratory Services, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India | en_US |
dc.identifier.affiliations | Department of Nuclear Medicine, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India | en_US |
dc.identifier.citation | Doval Dinesh Chandra, Tripathi Rupal, Choudhury Kumardeep Dutta, Sharma Ajay, Batra Ullas, Mehta Anurag, Choudhury PS. Case Report of Non-small Cell Lung Cancer Patient with EGFR T790M Mutation Treated with Th ird Generation Inhibitor. Indian Journal of Medical Sciences. 2019 Jan; 71(1): 49-51 | en_US |
dc.identifier.issn | 0019-5359 | |
dc.identifier.issn | 1998-3654 | |
dc.identifier.place | India | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/196516 | |
dc.language | en | en_US |
dc.publisher | Scientific Scholar | en_US |
dc.relation.issuenumber | 1 | en_US |
dc.relation.volume | 71 | en_US |
dc.source.uri | https://doi.org/10.25259/IJMS_9_2019 | en_US |
dc.subject | Non-small cell lung cancer | en_US |
dc.subject | T790M | en_US |
dc.subject | Osimertinib | en_US |
dc.title | Case Report of Non-small Cell Lung Cancer Patient with EGFR T790M Mutation Treated with Th ird Generation Inhibitor | en_US |
dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1